Category: Laboratories

Moderna’s COVID-19 Vaccine Candidate Meets its Primary Efficacy Endpoint in the First Interim Analysis of the Phase 3 COVE Study
Read More

Moderna Completes Enrollment of Phase 3 COVE Study of mRNA Vaccine Against COVID-19 (mRNA-1273)
Read More

Mitigating Impacts of a Global Pandemic in the Clinical Development Space
Read More

Enhancing Communication Between Clinical Trial Sites and the Central Lab During a Global Pandemic
Read More

PPD’s Patient Data Dashboard: Moving Data Review Forward Today and Beyond
Read More

How COVID-19 is Changing the Approach for the Vaccine Development Process
Read More

Moderna Announces Phase 3 COVE Study of mRNA Vaccine Against COVID-19 (mRNA-1273) Begins
Read More
Implementing the Estimands Framework in Clinical Trials
Read More
Virtual Lab Quality Audits: Are They Here to Stay?
Read More